Share this Post!

The Food and Drug Administration (FDA) participated in the three-day World Trade Organization-Technical Barriers to Trade (WTO-TBT) National Workshop on 13-15 September. The workshop conducted by the Department of Trade and Industry-Bureau of Philippine Standards (DTI-BPS) in collaboration with the Bureau of International Trade Relations (BITR), aimed to deepen the understanding of the WTO-TBT Agreement among key stakeholders in the Philippines and to strengthen the implementation of the agreement by various government agencies.

Speakers from the WTO Secretariat, International Organization for Standardization (ISO), International Electrotechnical Commission (IEC), International Telecommunication Union (ITU), and Codex Alimentarius were invited to share their work and how their activities support the WTO-TBT Agreement implementation. Further, speakers from the Anti-Red Tape Authority (ARTA), DTI-Bureau of Philippine Standards (DTI-BPS), including Food and Drug Administration (FDA), were also invited to discuss Good Regulatory Practices (GRPs), and procedures on drafting and adopting technical regulations.

Director General Dr. Samuel A. Zacate expressed his support for the said workshop, emphasizing that with the Technical Barriers to Trade (TBT) agreement, it will be ensured that technical regulations, standards, and conformity assessment procedures are non-discriminatory and do not create unnecessary obstacles to trade.

Through the workshop, the FDA, as a regulatory agency that formulates and implements regulatory policies mandated to ensure the safety, quality, and efficacy of health products available in the market for the general public, will be extensively guided on the procedure of filing notifications for draft technical regulations affecting international trade.

See more:>>